← Open Payments lookup

PATRICIA DUFF: Open Payments

NPI 1043609647 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,715 in 48 payments from 13 companies in 2025. Trend: 2023 $891 · 2024 $1,008 · 2025 $1,715

Food & beverage: $1,715
CompanyPaymentsAmount
Edwards Lifesciences Corporation23$1,078
Boston Scientific Corporation4$157
AstraZeneca Pharmaceuticals LP4$99
Novartis Pharmaceuticals Corporation4$87
E.R. Squibb & Sons, L.L.C.3$84
PFIZER INC.2$47
Boehringer Ingelheim Pharmaceuticals, Inc.2$39
AtriCure, Inc.1$30
Bayer Healthcare Pharmaceuticals Inc.1$21
Novo Nordisk Inc1$21

Products named: SAPIEN 3 Ultra RESILIA, General - Vascular Intervention, LEQVIO, CAMZYOS, FARXIGA, VYNDAQEL, JARDIANCE, ELIQUIS.

Industry payments across MD — which companies pay providers there.